GOGFX
Price
$47.15
Change
+$0.42 (+0.90%)
Updated
Jun 12 closing price
Net Assets
4.71B
SSGSX
Price
$52.92
Change
+$0.47 (+0.90%)
Updated
Jun 12 closing price
Net Assets
4.71B
Interact to see
Advertisement

GOGFX vs SSGSX

Header iconGOGFX vs SSGSX Comparison
Open Charts GOGFX vs SSGSXBanner chart's image
GOGFX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
GOGFX vs. SSGSX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOGFX is a Buy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GOGFX (4.71B) and SSGSX (4.71B) have equal amount of cash in the bank . SSGSX pays higher dividends than GOGFX: SSGSX (0.54) vs GOGFX (0.46). GOGFX was incepted earlier than SSGSX: GOGFX (43 years) vs SSGSX (27 years). GOGFX (1.44) is less costly to investors than SSGSX (1.23). GOGFX (50.00) and SSGSX (50.00) have comparable annual turnover. GOGFX has a lower initial minimum investment than SSGSX: GOGFX (0) vs SSGSX (2500). SSGSX (22.96) and GOGFX (22.02) have marching annual gain over last year. SSGSX return over 5 years is better than : -4.91 vs. GOGFX (-9.03).
GOGFXSSGSXGOGFX / SSGSX
Total Expense Ratio1.441.23117%
Annual Report Gross Expense Ratio1.441.23117%
Fund Existence43 years27 years-
Gain YTD18.31918.41699%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B4.71B100%
Annual Yield % from dividends0.460.5486%
Returns for 1 year22.0222.9696%
Returns for 3 years11.1314.0379%
Returns for 5 years-9.03-4.91184%
Returns for 10 years35.8045.7978%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VOR14.360.27
+1.92%
Vor Biopharma Inc
CFG67.651.14
+1.71%
Citizens Financial Group
VCYT47.33-0.09
-0.19%
Veracyte
MARPS4.64-0.06
-1.17%
Marine Petroleum Trust
EPM4.16-0.09
-2.12%
Evolution Petroleum Corp